Aleglitazar

Aleglitazar

Names
IUPAC name (2S)-2-methoxy-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-7-benzothiophenyl]propanoic acid
Other names Ro-0728804, R-1439
Identifiers
CAS Number	475479-34-6
ChEMBL	ChEMBL519504
ChemSpider	8450255
DrugBank	DB08483
IUPHAR/BPS	7405
Jmol interactive 3D	Image Image
KEGG	D08845
PubChem	10274777
UNII	41T4OAG59U
InChI InChI=1S/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1 Key: DAYKLWSKQJBGCS-NRFANRHFSA-N InChI=1/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1 Key: DAYKLWSKQJBGCS-NRFANRHFBF
SMILES CC1=C(CCOc2ccc(C[C@H](OC)C(O[H])=O)c3c2C=CS3)N=C(c4ccccc4)O1 O=C(O)[C@@H](OC)Cc4ccc(OCCc1nc(oc1C)c2ccccc2)c3c4scc3
Properties
Chemical formula	C24H23NO5S
Molar mass	437.51 g·mol^−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
verify (what is  ?)
Infobox references

Aleglitazar is a peroxisome proliferator-activated receptor agonist (hence a PPAR modulator ) with affinity to PPARα and PPARγ, which was under development by Hoffmann–La Roche for the treatment of type II diabetes.^[1] It is no longer in phase III clinical trials.^[2]

References

1. "Statement on a nonproprietary name adopted by the USAN Council: Aleglitazar" (PDF). United States Adopted Names. American Medical Association. Retrieved 2008-08-17.
2. "Roche halts diabetes drug trial in blow to pipeline". Roche. Retrieved 2013-07-10.